Literature DB >> 20963592

A missense mutation in LRR8 of RXFP2 is associated with cryptorchidism.

Rebecca M Harris1, Courtney Finlayson, Jeffrey Weiss, Lisa Fisher, Lisa Hurley, Tim Barrett, Donna Emge, Ross A D Bathgate, Alexander I Agoulnik, J Larry Jameson.   

Abstract

Using genome-wide mutagenesis with N-ethyl-N-nitrosourea (ENU), a mouse mutant with cryptorchidism was identified. Genome mapping and exon sequencing identified a novel missense mutation (D294G) in Relaxin/insulin-like family peptide receptor 2 (Rxfp2). The mutation impaired testicular descent and resulted in decreased testis weight in Rxfp2 ( DG/DG ) mice compared to Rxfp2 (+/DG ) and Rxfp2 (+/+) mice. Testicular histology of the Rxfp2 ( DG/DG ) mice revealed spermatogenic defects ranging from germ cell loss to tubules with Sertoli-cell-only features. Genetic complementation analysis using a loss-of-function allele (Rxfp2 (-)) confirmed causality of the D294G mutation. Specifically, mice with one of each mutant allele (Rxfp2 ( DG/-)) exhibited decreased testis weight and failure of the testes to descend compared to their Rxfp2 (+/-) littermates. Total and cell-surface expression of mouse RXFP2 protein and intracellular cAMP accumulation were measured. Total expression of the D294G protein was minimally reduced compared to wild-type, but cell-surface expression was markedly decreased. When analyzed for cAMP accumulation, the EC50 was similar for cells transfected with wild-type and mutant RXFP2 receptor. However, the maximum cAMP response that the mutant receptor reached was greatly reduced compared to the wild-type receptor. In silico modeling of leucine rich repeats (LRRs) 7-9 indicated that aspartic acid 294 is located within the β-pleated sheet of LRR8. We thus postulate that mutation of D294 results in protein misfolding and aberrant trafficking. The ENU-induced D294G mutation underscores the role of the INSL3/RXFP2-mediated pathway in testicular descent and expands the repertoire of mutations known to affect receptor trafficking and function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20963592     DOI: 10.1007/s00335-010-9291-5

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  28 in total

1.  A transgenic insertion causing cryptorchidism in mice.

Authors:  P A Overbeek; I P Gorlov; R W Sutherland; J B Houston; W R Harrison; H L Boettger-Tong; C E Bishop; A I Agoulnik
Journal:  Genesis       Date:  2001-05       Impact factor: 2.487

2.  Discordance of monozygotic twins for thyroid dysgenesis: implications for screening and for molecular pathophysiology.

Authors:  Rebecca Perry; Claudine Heinrichs; Pierre Bourdoux; Khalil Khoury; François Szöts; Jean H Dussault; Gilbert Vassart; Guy Van Vliet
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

Review 3.  Maldescendus testis.

Authors:  J Toppari; M Kaleva
Journal:  Horm Res       Date:  1999-12

4.  Cryptorchidism in mice mutant for Insl3.

Authors:  S Nef; L F Parada
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

5.  Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules.

Authors:  Daniel J Scott; Sharon Layfield; Yan Yan; Satoko Sudo; Aaron J W Hsueh; Geoffrey W Tregear; Ross A D Bathgate
Journal:  J Biol Chem       Date:  2006-09-08       Impact factor: 5.157

6.  T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane.

Authors:  Natalia V Bogatcheva; Alberto Ferlin; Shu Feng; Anne Truong; Lisa Gianesello; Carlo Foresta; Alexander I Agoulnik
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-08-22       Impact factor: 4.310

7.  Transabdominal testicular descent is disrupted in mice with deletion of insulinlike factor 3 receptor.

Authors:  Hideki Tomiyama; John M Hutson; Anne Truong; Alexander I Agoulnik
Journal:  J Pediatr Surg       Date:  2003-12       Impact factor: 2.545

8.  Genetic alterations associated with cryptorchidism.

Authors:  Alberto Ferlin; Daniela Zuccarello; Biagio Zuccarello; Maria Rosaria Chirico; Giovanni Franco Zanon; Carlo Foresta
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

9.  Mutations of the GREAT gene cause cryptorchidism.

Authors:  Ivan P Gorlov; Aparna Kamat; Natalia V Bogatcheva; Eric Jones; Dolores J Lamb; Anne Truong; Colin E Bishop; Ken McElreavey; Alexander I Agoulnik
Journal:  Hum Mol Genet       Date:  2002-09-15       Impact factor: 6.150

10.  Mutations in INSL3 and RXFP2 genes in cryptorchid boys.

Authors:  Alberto Ferlin; Daniela Zuccarello; Andrea Garolla; Riccardo Selice; Cinzia Vinanzi; Francesco Ganz; Gian Franco Zanon; Biagio Zuccarello; Carlo Foresta
Journal:  Ann N Y Acad Sci       Date:  2009-04       Impact factor: 5.691

View more
  4 in total

1.  ENU mutagenesis in mice identifies candidate genes for hypogonadism.

Authors:  Jeffrey Weiss; Lisa A Hurley; Rebecca M Harris; Courtney Finlayson; Minghan Tong; Lisa A Fisher; Jennifer L Moran; David R Beier; Christopher Mason; J Larry Jameson
Journal:  Mamm Genome       Date:  2012-01-19       Impact factor: 2.957

2.  E2F1 regulates testicular descent and controls spermatogenesis by influencing WNT4 signaling.

Authors:  Carolina J Jorgez; Abhishek Seth; Nathan Wilken; Juan C Bournat; Ching H Chen; Dolores J Lamb
Journal:  Development       Date:  2021-01-13       Impact factor: 6.868

3.  Pivotal role of the muscle-contraction pathway in cryptorchidism and evidence for genomic connections with cardiomyopathy pathways in RASopathies.

Authors:  Carlo V Cannistraci; Jernej Ogorevc; Minja Zorc; Timothy Ravasi; Peter Dovc; Tanja Kunej
Journal:  BMC Med Genomics       Date:  2013-02-14       Impact factor: 3.063

4.  Diethylstilbestrol Regulates the Expression of LGR8 in Mouse Gubernaculum Testis Cells.

Authors:  Shouxing Duan; Xuewu Jiang; Xuan Zhang; Lei Xie; Zongbo Sun; Shuhua Ma; Jianhong Li
Journal:  Med Sci Monit       Date:  2016-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.